InspireMD Set to Reveal 2024 Year-End Financial Results

InspireMD's Upcoming Financial Results Announcement
InspireMD, Inc. (NASDAQ: NSPR), known for developing the revolutionary CGuard™ Prime carotid stent system, is gearing up to announce its fourth quarter and full year financial results for 2024. The reveal is scheduled for March 12, 2025, showcasing the company's latest advancements and updates following a productive year.
Conference Call Details
In conjunction with the financial results release, InspireMD will conduct a conference call and a live webcast beginning at 8:30 a.m. Eastern Time. This event aims to provide shareholders and interested parties with an in-depth overview of the company’s financial health and strategic direction. Participants can dial in using designated phone numbers depending on their location.
Accessing the Financial Call
For those who wish to join the live earnings call, domestic callers can connect at 1-800-579-2543, while international attendees should use 1-785-424-1789. Interested parties can also participate through the Events Section of the InspireMD investor relations website.
About InspireMD, Inc.
InspireMD is on a mission to set new benchmarks in the carotid stenting industry through its proprietary MicroNet technology. This innovative approach is designed to ensure patients experience remarkable acute outcomes along with long-lasting, stroke-free results. The company's common stock trades on the Nasdaq under the ticker symbol NSPR, and they consistently engage with investors via their website to keep them informed.
Company Highlights
As InspireMD prepares for the upcoming financial announcement, it's worth noting the company’s commitment to research and innovation in the field of carotid artery disease (CAD). The CGuard™ Prime system, which has received accolades for its design and effectiveness, underscores InspireMD's dedication to advancing medical technology for improved patient care.
Investor Relations and Contact Information
InspireMD encourages investors to stay updated through their dedicated investor relations page, where a wealth of information is available regarding annual reports, press releases, and upcoming events. For any inquiries, investors are welcome to contact Craig Shore, the Chief Financial Officer, at 888-776-6804 or via email.
Frequently Asked Questions
What is InspireMD known for?
InspireMD is recognized for developing the CGuard™ Prime carotid stent system, utilized in treating carotid artery disease.
When will InspireMD announce its financial results?
The financial results for the fourth quarter and full year of 2024 will be announced on March 12, 2025.
How can I access the earnings call?
Interested parties can join the earnings call by dialing specific phone numbers for domestic and international callers, or they can attend via the company’s investor website.
What stock exchange is InspireMD listed on?
InspireMD's common stock is traded on the Nasdaq under the ticker symbol NSPR.
Who can I contact for investor relations?
Craig Shore, the Chief Financial Officer of InspireMD, is available at 888-776-6804 for any investor relations inquiries.
About The Author
Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.